Pipeline & development

A disciplined path toward clinical evaluation.

The Vaxiferon® program is advancing through preclinical and development planning toward future regulatory submission and first clinical evaluation.

Development roadmap

From candidate to proof of concept

Future stages are targeted and remain subject to successful development, regulatory review and financing. No regulatory or clinical milestone has been completed.

01In progress

Preclinical development

02In progress

Candidate optimization

03Planned

CMC & process development

04Planned

GMP manufacturing

05Planned

Regulatory preparation

06Planned

CTA / IND submission

07Planned

First clinical evaluation

08Planned

Clinical proof of concept

Intellectual property

Protected innovation

The company is pursuing an international patent strategy around its composite vaccine approach.

Main patent

PCT/EP2023/084994

Inventor: Prof. Daniel Zagury

Proprietary technology

Composite vaccine strategy

International strategy

Applications progressing in key markets

Strategic protection

Designed to support long-term development

World map indicating territories covered by the international patent filings — International patent protection in progress — map of the international patent filings, reproduced from the Dys-Immune Therapeutics presentation (original French: “Protection internationale en cours”).

The platform may support future expansion beyond HIV following validation of the core technology.

Explore the platform science